Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 08:20 am Purchase | 2024-02-12 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,716,242 4.100% | 594,142 (+19.03%) | Filing History |
| 2023-08-10 3:25 pm Purchase | 2023-07-31 | 13G | Avadel Pharmaceuticals plc AVDL | JANUS HENDERSON GROUP PLC JHG | 9,443,642 12.300% | 9,443,642 (New Position) | Filing History |
| 2023-03-09 4:13 pm Purchase | 2023-02-14 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,122,100 5.100% | 265,110 (+9.28%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Tontine Asset Associates, LLC | 5,190,605 8.400% | 1,015,623 (+24.33%) | Filing History |
| 2023-02-14 10:01 am Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,741,939 9.300% | -68,201 (-1.17%) | Filing History |
| 2023-02-13 5:42 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,251,663 3.600% | -149,613 (-6.23%) | Filing History |
| 2023-02-13 4:58 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 2,856,990 4.600% | -583,222 (-16.95%) | Filing History |
| 2022-06-06 4:57 pm Purchase | 2022-05-26 | 13G | Avadel Pharmaceuticals plc AVDL | KOTLER KEVIN | 3,440,212 5.800% | 3,440,212 (New Position) | Filing History |
| 2022-06-03 4:10 pm Purchase | 2022-05-27 | 13G | Avadel Pharmaceuticals plc AVDL | Tontine Asset Associates, LLC | 4,174,982 7.070% | 4,174,982 (New Position) | Filing History |
| 2022-02-14 10:40 am Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 2,794,673 4.800% | -233,032 (-7.70%) | Filing History |
| 2022-02-14 08:12 am Purchase | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,810,140 9.990% | 422,627 (+7.84%) | Filing History |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,401,276 4.100% | -481,548 (-16.70%) | Filing History |
| 2022-02-11 10:07 am Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Avoro Capital Advisors LLC | 1,670,000 2.900% | -2,695,000 (-61.74%) | Filing History |
| 2022-02-08 12:44 pm Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | BRANDES INVESTMENT PARTNERS, LP | 2,599,633 4.430% | -362,245 (-12.23%) | Filing History |
| 2022-01-21 11:12 am Purchase | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY, LLC | 3,732,778 6.370% | 691,154 (+22.72%) | Filing History |
| 2021-11-12 2:11 pm Purchase | 2021-11-09 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY, LLC | 3,041,624 5.180% | 3,041,624 (New Position) | Filing History |
| 2021-02-16 07:32 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Polar Capital Holdings Plc | 3,027,705 5.200% | 3,027,705 (New Position) | Filing History |
| 2021-02-12 09:34 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,387,513 9.260% | 1,986,079 (+58.39%) | Filing History |
| 2021-02-12 08:07 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Avoro Capital Advisors LLC | 4,365,000 7.500% | 4,365,000 (New Position) | Filing History |
| 2021-02-11 4:21 pm Sale | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | BRANDES INVESTMENT PARTNERS, LP | 2,961,878 5.080% | -690,070 (-18.90%) | Filing History |